Title:
PHARMACEUTICAL COMPOSITION AND DIETARY SUPPLEMENT FOR PREVENTING OR TREATING OVERACTIVE BLADDER CAUSED BY SECONDARY BLADDER DEGENERATION DUE TO BLADDER OUTLET OBSTRUCTION CAUSED BY BENIGN PROSTATIC HYPERPLASIA
Document Type and Number:
WIPO Patent Application WO/2017/164707
Kind Code:
A1
Abstract:
The present invention contains Cornus officinalis fruit, Angelica gigas, Lycium chinense, deer antler, red ginseng and Cinnamomum cassia Presl extracts and a blocker selectively acting on an alpha-1A adrenergic receptor, thereby exhibiting excellent medicinal effects on an overactive bladder caused by secondary bladder degeneration due to bladder outlet obstruction caused by benign prostatic hyperplasia. Particularly, the present invention relates to a pharmaceutical composition and a dietary supplement for preventing or treating an overactive bladder, which is a complication of benign prostatic hyperplasia, the composition being capable of exhibiting excellent medicinal effects even on an overactive bladder of which the main cause is not resolved even when bladder outlet obstruction disappears because of benign prostatic hyperplasia surgical therapy or administration of an alpha-blocker and the like.
Inventors:
HWANG SUNG YEOUN (KR)
KIM SAE WOONG (KR)
KIM SAE WOONG (KR)
Application Number:
PCT/KR2017/003228
Publication Date:
September 28, 2017
Filing Date:
March 24, 2017
Export Citation:
Assignee:
KEMIMEDI CO LTD (KR)
THE CATHOLIC OF KOREA INDUSTRY-ACADEMIC COOP FOUND (KR)
THE CATHOLIC OF KOREA INDUSTRY-ACADEMIC COOP FOUND (KR)
International Classes:
A61K36/40; A23L33/105; A61K35/32; A61K36/232; A61K36/258; A61K36/54; A61K36/815
Foreign References:
| KR20150083467A | 2015-07-20 | |||
| US20050124607A1 | 2005-06-09 | |||
| KR20100105346A | 2010-09-29 | |||
| KR101348102B1 | 2014-01-07 |
Other References:
LEPOR, H.: "Alpha Blockers for the Treatment of Benign Prostatic Hyperplasia", REVIEWS IN UROLOGY, vol. 9, no. 4, 2007, pages 181 - 190, XP055300018
Attorney, Agent or Firm:
DOOHO IP LAW FIRM (KR)
Download PDF: